Riya Exim Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.60 Cr
- Revenue Growth -34.78%
- Profit Growth -92.37%
- Ebitda -94.05%
- Net Worth 17.14%
- Total Assets -32.66%
About Riya Exim
Riya Exim Private Limited (REPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 July 2014 and has a history of Ten years and seven months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ushaben Patel, Pravinkumar Patel, and Hemal Patel serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100GJ2014PTC080170
- Company No.
080170
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2014
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Riya Exim?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ushaben Patel  | Director | 21-Jul-2014 | Current |
| Pravinkumar Patel | Director | 21-Jul-2014 | Current |
| Hemal Patel | Director | 08-Mar-2016 | Current |
Financial Performance of Riya Exim.
Riya Exim Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 34.78% decrease. The company also saw a substantial fall in profitability, with a 92.37% decrease in profit. The company's net worth Soared by an impressive increase of 17.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riya Exim?
In 2018, Riya Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Praspack Industries Private LimitedUshaben Patel and Pravinkumar Patel are mutual person
Prachem Laboratories Private LimitedPravinkumar Patel is a mutual person
Charges (Loans)
₹0
₹16.00 M
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
- Hdfc Bank Limited : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2019 | Hdfc Bank Limited | ₹6.00 M | Satisfied |
| 31 Mar 2016 | Others | ₹1.00 Cr | Satisfied |
How Many Employees Work at Riya Exim?
Unlock and access historical data on people associated with Riya Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riya Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riya Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
